• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

AdvanDx

edit

AdvanDx, Inc. develops and markets vitro diagnostic kits for the diagnosis and prevention of infectious diseases.

The company provides its products to medical centers, reference labs, government institutions, and community hospitals. Its products are available through a network of sales force in United States, as well as through distributors around the world.

AdvanDX was founded in 2002 and is based in Woburn, Massachusetts.

Recent Milestones

edit

• 
  AdvanDx received $2.2M in Venture Round funding. (10/29/12)
  Posted 10/29/12 at 6:25pm via masshightech.com
• 
  AdvanDx — has won approval from the FDA for its speedy blood test for simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa infections (1/17/11)
  Posted 1/17/11 at 10:59am via masshightech.com
• 
  AdvanDx received $8M in Series C funding. (10/12/09)
  Posted 10/12/09 at 6:05pm via onbiovc.com
• 
  AdvanDx added Thais T. Johansen as Founder.
  Posted 10/12/09 at 6:05pm
• 
  AdvanDx added Henrik Stender as Founder.
  Posted 10/12/09 at 6:05pm

Videos

Screenshots

edit

Sources

1. AdvanDx, Inc.: Series C $8M (onbiovc.com) [edit]
2. AdvanDx gets $2.2M funding (masshightech.com) [edit]
AdvanDx wins FDA OK for speedy blood infection test (masshightech.com) [edit]